Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
International Journal of Urology : Official Journal of the Japanese Urological Association|August 6, 2026
Real-World Outcomes of Olaparib Treatment in Japanese Patients With Metastatic Castration-Resistant Prostate Cancer Harboring BRCA Pathogenic or Likely Pathogenic VariantsYosuke Yasuda, Soichiro Yoshida, Ichiro Yonese, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 30, 2019
Impact of fluorodeoxyglucose uptake on positron emission tomography/computed tomography on chemosensitivity and survival in patients with metastatic urothelial carcinomaMasaki Kobayashi, Hajime Tanaka, Ukihide Tateishi, et al.
Clinical Genitourinary Cancer|September 21, 2025
Impact of Impaired Renal Function on the Efficacy and Safety of Enfortumab Vedotin Monotherapy in a Multicenter Real-World Cohort of Patients With Metastatic Urothelial Cancer: YUSHIMA StudyHiroshi Fukushima, Yuki Nakamura, Hajime Tanaka, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 16, 2024
Outcomes and prognostic factors in patients with synchronous and metachronous oligometastatic urothelial carcinoma with visceral metastasesSoichiro Yoshida, Yuya Maezawa, Kensaku Ishihara, et al.
Endocrine Journal|June 28, 2021
Japanese single-institution analysis of mitotane for patients with adrenocortical carcinomaAkihiro Ohmoto, Yasuyuki Shigematsu, Naoki Fukuda, et al.
International Urology and Nephrology|September 12, 2013
Apparent diffusion coefficient value as a biomarker reflecting morphological and biological features of prostate cancerHyeyeol Bae, Soichiro Yoshida, Yoh Matsuoka, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 11, 2026
Prognostic Significance of Hypoalbuminemia in Maintenance Avelumab Therapy After First-Line Chemotherapy for Metastatic Urothelial Carcinoma: A Multicenter Real-World Study (YUSHIMA Study)Rie Muta, Hiroshi Fukushima, Hajime Tanaka, et al.
Clinical Genitourinary Cancer|August 18, 2020
Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature ReviewToshiki Kijima, Hiroshi Fukushima, Shota Kusuhara, et al.
Clinical Genitourinary Cancer|January 28, 2025
Enfortumab Vedotin for Metastatic Urothelial Carcinoma: Comprehensive Treatment Outcomes and Prognostic Insights From a Multicenter Real-World Study (YUSHIMA Study)Yuki Nakamura, Hajime Tanaka, Noboru Numao, et al.
International Journal of Clinical Oncology|April 21, 2025
Prognostic factors and effect of existing predictive models in oligo-metastatic urothelial carcinoma (YUSHIMA study)Kenji Tanabe, Soichiro Yoshida, Tomoki Kimura, et al.
Pageof 13